VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 235 filers reported holding VERACYTE INC in Q1 2021. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $169,564,898 | -15.0% | 7,593,592 | -3.0% | 1.30% | -1.7% |
Q2 2023 | $199,386,601 | +6.3% | 7,828,292 | -6.9% | 1.32% | +2.4% |
Q1 2023 | $187,523,064 | -4.8% | 8,409,106 | +1.3% | 1.29% | -24.5% |
Q4 2022 | $196,964,719 | +30.7% | 8,300,241 | -8.6% | 1.71% | +62.4% |
Q3 2022 | $150,751,000 | -3.2% | 9,081,363 | +2.5% | 1.05% | +14.1% |
Q2 2022 | $155,693,000 | -35.5% | 8,856,245 | +1.1% | 0.92% | -8.6% |
Q1 2022 | $241,404,000 | -28.7% | 8,756,024 | +6.5% | 1.01% | -1.6% |
Q4 2021 | $338,758,000 | +4.5% | 8,222,281 | +17.8% | 1.02% | +31.5% |
Q3 2021 | $324,230,000 | +21.2% | 6,980,201 | +4.3% | 0.78% | +56.4% |
Q2 2021 | $267,437,000 | -34.7% | 6,689,263 | -12.2% | 0.50% | -38.7% |
Q1 2021 | $409,429,000 | -7.3% | 7,617,287 | -15.6% | 0.81% | -30.9% |
Q4 2020 | $441,822,000 | +93.7% | 9,027,827 | +28.6% | 1.18% | -13.0% |
Q3 2020 | $228,040,000 | +73.9% | 7,018,770 | +38.6% | 1.35% | -4.2% |
Q2 2020 | $131,152,000 | +65.2% | 5,063,793 | +55.1% | 1.41% | -28.7% |
Q1 2020 | $79,393,000 | +2.0% | 3,265,859 | +17.1% | 1.98% | +0.8% |
Q4 2019 | $77,853,000 | +25.6% | 2,788,436 | +8.0% | 1.96% | +45.2% |
Q3 2019 | $61,987,000 | -28.4% | 2,582,798 | -14.9% | 1.35% | -38.0% |
Q2 2019 | $86,575,000 | +0.0% | 3,036,653 | -12.2% | 2.18% | -11.8% |
Q1 2019 | $86,546,000 | +96.9% | 3,459,073 | -1.0% | 2.47% | +38.6% |
Q4 2018 | $43,945,000 | +16.8% | 3,493,255 | -11.4% | 1.78% | +56.9% |
Q3 2018 | $37,635,000 | +7.1% | 3,940,804 | +4.8% | 1.14% | -11.7% |
Q2 2018 | $35,125,000 | +124.7% | 3,760,659 | +33.8% | 1.29% | +65.9% |
Q1 2018 | $15,631,000 | +70.7% | 2,811,294 | +100.5% | 0.78% | +6.4% |
Q4 2017 | $9,157,000 | +574.3% | 1,402,264 | +760.2% | 0.73% | +176.1% |
Q2 2017 | $1,358,000 | +146.9% | 163,020 | +172.3% | 0.26% | +66.0% |
Q1 2017 | $550,000 | +56.7% | 59,863 | +32.0% | 0.16% | +24.2% |
Q4 2016 | $351,000 | – | 45,351 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PERKINS CAPITAL MANAGEMENT INC | 119,680 | $2,672 | 2.65% |
SILVERARC CAPITAL MANAGEMENT, LLC | 239,571 | $5,349,620 | 1.62% |
OBERWEIS ASSET MANAGEMENT INC/ | 597,540 | $13,343,068 | 1.42% |
ARK Investment Management | 7,593,592 | $169,564,898 | 1.30% |
Capital Impact Advisors, LLC | 32,969 | $736,198 | 1.23% |
EFG Asset Management (North America) Corp. | 229,837 | $5,127,663 | 1.22% |
Parkman Healthcare Partners LLC | 225,872 | $5,043,722 | 0.92% |
Nikko Asset Management Americas, Inc. | 3,173,576 | $70,770,745 | 0.85% |
Granite Investment Partners, LLC | 865,770 | $19,332,644 | 0.81% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 175,749 | $3,924,475 | 0.64% |